NCT03422679 2024-01-16
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
Cellestia Biotech AG
Phase 1/2 Terminated
Cellestia Biotech AG
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins